Related references
Note: Only part of the references are listed.α-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia
Andis Klegeris et al.
NEUROBIOLOGY OF AGING (2008)
Oligomeric α-synuclein inhibits tubulin polymerization
Leo Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Observation of multiple intermediates in α-synuclein fibril formation by singular value decomposition analysis
Tomoaki Kamiyoshihara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
α-synuclein expression modulates microglial activation phenotype
Susan A. Austin et al.
JOURNAL OF NEUROSCIENCE (2006)
Raft-mediated Src homology 2 domain-containing protein-tyrosine phosphatase 2 (SHP-2) regulation in microglia
HY Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Amino acid sequence motifs and mechanistic features of the membrane translocation of α-synuclein
KJ Ahn et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
An inflammatory pathomechanism for Parkinson's disease?
C Wersinger et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Microglial phagocytosis induced by fibrillar β-amyloid and IgGs are differentially regulated by proinflammatory cytokines
J Koenigsknecht-Talboo et al.
JOURNAL OF NEUROSCIENCE (2005)
Intravesicular localization and exocytosis of α-synuclein and its aggregates
HJ Lee et al.
JOURNAL OF NEUROSCIENCE (2005)
Aggregated α-synuclein activates microglia:: a process leading to disease progression in Parkinson's disease
W Zhang et al.
FASEB JOURNAL (2005)
Fibrillar prion peptide (106-126) and scrapie prion protein hamper phagocytosis in microglia
J Ciesielski-Treska et al.
GLIA (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Microglial phagocytosis of fibrillar β-amyloid through a β1 integrin-dependent mechanism
J Koenigsknecht et al.
JOURNAL OF NEUROSCIENCE (2004)
Oxidized glutathione stimulated the amyloid formation of α-synuclein
SR Paik et al.
FEBS LETTERS (2003)
An inflammatory review of Parkinson's disease
CF Orr et al.
PROGRESS IN NEUROBIOLOGY (2002)
Evidence that α-synuclein functions as a negative regulator of Ca+ +-dependent α-granule release from human platelets
SM Park et al.
BLOOD (2002)
Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human α-synuclein
J Li et al.
BIOCHEMISTRY (2001)
Induction of neuronal cell death by Rab5A-dependent endocytosis of α-synuclein
JY Sung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Brain dendritic cells and macrophages/microglia in central nervous system inflammation
HG Fischer et al.
JOURNAL OF IMMUNOLOGY (2001)
Wild-type but not Parkinson's disease-related Ala-53 → Thr mutant α-synuclein protects neuronal cells from apoptotic stimuli
CA da Costa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Induction of neuronal death by α-synuclein
AR Saha et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects
R Borghi et al.
NEUROSCIENCE LETTERS (2000)
Chaperone-like activity of synucleins
JM Souza et al.
FEBS LETTERS (2000)
Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
LC Serpell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A Drosophila model of Parkinson's disease
MB Feany et al.
NATURE (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)